Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $475 Million
  • Q1 2024

Johnson & Johnson has filed its 13F form on May 10, 2024 for Q1 2024 where it was disclosed a total value porftolio of $475 Million distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Fusion Pharmaceuticals Inc. with a value of $78.3M, Cv Rx, Inc. with a value of $74.7M, Protagonist Therapeutics, Inc with a value of $70.9M, Shockwave Medical, Inc. with a value of $54.3M, and Legend Biotech Corp with a value of $45.7M.

Examining the 13F form we can see an increase of $216M in the current position value, from $259M to 475M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $475 Million
Healthcare: $475 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$78.3 Million 16.48% of portfolio
3,670,516
Q3 2021 New
$247M
$74.7 Million 15.74% of portfolio
4,103,430
Q1 2024 Added 17.39%
$1.7B
$70.9 Million 14.92% of portfolio
2,449,183
Q3 2021 New
$0
$54.3 Million 11.44% of portfolio
166,812
Q1 2024 New
$7.41B
$45.7 Million 9.62% of portfolio
814,586
Q2 2023 Reduced 50.0%
$189M
$40.3 Million 8.49% of portfolio
6,641,064
Q4 2022 Added 129.12%
$174M
$36.6 Million 7.7% of portfolio
5,623,816
Q1 2024 Added 486.04%
$318M
$24.8 Million 5.22% of portfolio
3,379,064
Q3 2021 New
$2.72B
$17.7 Million 3.73% of portfolio
357,939
Q4 2022 Reduced 58.57%
$1.13B
$16.6 Million 3.49% of portfolio
748,062
Q4 2021 New
$2.75B
$7.08 Million 1.49% of portfolio
247,598
Q3 2022 Reduced 80.36%
$38.1M
$2.55 Million 0.54% of portfolio
1,074,658
Q3 2021 New
$383M
$1.55 Million 0.33% of portfolio
158,852
Q1 2024 Reduced 50.0%
$193M
$979,000 0.21% of portfolio
299,669
Q1 2024 Reduced 24.1%
$10.2M
$865,000 0.18% of portfolio
1,923,201
Q1 2024 Reduced 9.85%
$48.4M
$856,000 0.18% of portfolio
364,472
Q1 2024 Reduced 50.0%
$78.2M
$259,000 0.05% of portfolio
169,629
Q4 2022 New
$186M
$28,000 0.01% of portfolio
54,621
Q3 2021 New
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 102.76%
Tracon Pharmaceuticals, Inc.
-
$0 0.0% of portfolio
-
Q3 2021 New
Kenvue Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 22
  • Current Value $475 Million
  • Prior Value $259 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 10, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 3 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email